Kathryn Josephs
About Kathryn Josephs
Kathryn Josephs serves as the Director of ISR/NRDG in Medical Affairs at Mirati Therapeutics, where she leads the Global Medical Affairs Investigator Sponsored/Collaborative Study program. With extensive experience in clinical research and trial management, she is recognized for her patient-centric approach and strategic oversight in oncology.
Work at Mirati Therapeutics
Kathryn Josephs serves as the Director of ISR/NRDG in Medical Affairs at Mirati Therapeutics since 2021. In this role, she leads the Global Medical Affairs Investigator Sponsored/Collaborative Study program, focusing on multiple solid tumor disease franchises. Her responsibilities include overseeing trial design, managing contract negotiations, and ensuring budget oversight. Kathryn is known for her patient-centric decision-making approach and her ability to provide insights for trial feasibility, leveraging her extensive site experience. She plays a strategic and operational role in managing both early and late-stage assets in oncology.
Education and Expertise
Kathryn Josephs studied at Boston University School of Medicine, where she earned a Master of Arts in Medical Science. Her educational background provides a strong foundation for her extensive work in clinical research and medical affairs. Kathryn's expertise encompasses trial design, evidence generation strategy, and managing competing priorities in a fast-paced therapeutic area. Her academic training complements her practical experience in the oncology sector.
Background in Clinical Research
Kathryn Josephs has a substantial background in clinical research, having worked at Dana-Farber Cancer Institute for seven years as a Senior Clinical Research Coordinator from 2007 to 2014. She transitioned to the role of Project Manager at the same institution for nine months in 2014, followed by two years as Clinical Research Manager from 2015 to 2017. Her experience at Dana-Farber laid the groundwork for her subsequent roles in clinical research management.
Experience at TESARO and GSK
Following her tenure at Dana-Farber Cancer Institute, Kathryn Josephs worked as a Clinical Research Manager at TESARO, Inc. from 2017 to 2020. She then joined GSK as a Medical Affairs Research Director in Global Medical Affairs, focusing on oncology, where she worked for nine months until 2021. These positions contributed to her comprehensive understanding of clinical research and medical affairs in the oncology field.